Fluicell logo

Om bolaget Analys Analytikerkommentar Video Textintervju

Fluicell is a fully-integrated life science company, offering a wide-ranging portfolio of products and projects. Its global presence spans pioneering research instruments and cutting-edge advancements in drug development, single-cell biology and 3D bioprinting applications. Since 2021, Fluicell’s strategic vision extends to shaping tissue-based therapeutics and disease models for progressive drug development within regenerative medicine. The Company was founded in 2012 in Gothenburg, Sweden, and is listed on the Nasdaq First North Growth Market since 2018. 


Tyvärr kan finansiell information för tillfället ej hämtas på detta bolag.